Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

177 results about "Polypill" patented technology

A polypill is a medication that is a drug product in pill form (i.e., tablet or capsule) that combines multiple active pharmaceutical ingredients. The prefix "poly" means "multiple", referring to the multiplicity of distinct drugs in a given "pill". An occasional synonym is combopill. It is commonly manufactured as a fixed-dose combination (FDC) drug product targeting treatment or prevention of chronic disease. Polypills may be aimed to be consumed by healthy people as a means of preventive medicine, and/or treating actual pathophysiological condition(s), the former typically involving lower dosages than the latter. Polypills can reduce the number of tablets or capsules (generally orally administered) that need to be taken, which in turn may facilitate handling and administration of pharmaceuticals as well as alleviate patient pill-burden. Sometimes the multiple drugs in a given polypill might all be aimed at a single underlying condition (or, group of related conditions), partly because this expands the pool of potential patients for whom a given combination of drugs/dosages might be appropriate (particularly in the case of mass-produced polypills, i.e. FDCs). The term polypill was first coined in the context of cardiovascular disease prevention, but has since gained broader acceptance, including now for combinatorial drug products that existed before the term was actually coined (as the bare term without any modifiers is now quite generic).

Edible and medicinal composition for dispelling effects of alcohol and protecting liver as well as preparation method and application of edible and medicinal composition

The invention discloses an edible and medicinal composition for dispelling effects of alcohol and protecting liver as well as a preparation method and application thereof, and belongs to the technical field of functional foods. The composition consists of the following raw materials in parts by weight: 1-8 parts of ampelopsis grossedentata extract freeze-dried powder, 1-8 parts of astragalus membranaceus extract freeze-dried powder, 1-5 parts of kudzu vine root extract freeze-dried powder, 1-8 parts of hawthorn extract freeze-dried powder and 1-5 parts of cassia seed extract freeze-dried powder. The composition is designed according to a multi-component synergistic interaction principle, and the functions of protecting the liver and dispelling the effects of alcohol are enhanced through targeted interaction of active ingredients such as ampelopsis grossedentata flavone, puerarin and astragaloside; the compound preparation has the compound effects of protecting the liver, dispelling the effects of alcohol, resolving dampness, resisting oxidative stress, regulating lipid metabolism and the like, can remarkably relieve the problems of acute and chronic liver injury and metabolic disorder caused by alcohol intake, and meets the food-grade safety standard and the medicinal activity requirement; the important application prospect is realized in the aspect of preparing a preparation for relieving alcoholic liver injury and improving the liver detoxification function.
Owner:NANJING JIANKE TONGCHUANG BIOTECHNOLOGY CO LTD +1

Compound antihypertensive pharmaceutical composition

The invention relates to the technical field of medicines, and particularly discloses a compound antihypertensive pharmaceutical composition. The pharmaceutical composition provided by the invention selects sacubitril valsartan sodium and indapamide as active ingredients, and within a prescription dosage range limited by the application, the two medicines can fully realize an antihypertensive effect through a synergistic effect, and the renal function of a patient is effectively improved. Through cooperation of the two components, the hypertension symptom of a patient can be effectively controlled, the adverse reaction is not obvious, and the compliance of the patient can be improved by adopting the compound preparation, so that the control on the blood pressure of the patient is enhanced.
Owner:NANJING ZENKOM PHARMA

Sarcandra glabra compound preparation and preparation method thereof

The invention provides a sarcandra glabra and honeysuckle compound preparation and a preparation method thereof, and during preparation, part of sarcandra glabra and honeysuckle are subjected to supercritical carbon dioxide extraction, volatile oil and medicine residues are collected, and the medicine residues and the rest of sarcandra glabra and honeysuckle are subjected to water extraction. A proper amount of beta-cyclodextrin is added into a water extract for inclusion, then concentration and supercritical extraction are performed to obtain volatile oil, and beta-cyclodextrin is used for inclusion, so that on the basis of increasing the efficacy of the volatile oil, the contents of chlorogenic acid and isofraxidin are increased, the curative effect of the medicine is enhanced, the synergistic effect of all components of the medicine is exerted, and the treatment effect of the medicine is improved. Menthol is clathrated with beta-cyclodextrin and then added into the paste powder to be mixed, granulated and tableted. On the premise of not influencing the dissolution of menthol and the direct stimulation effect on the throat, the effects of dispelling wind, clearing heat, relieving sore throat and relieving pain of the medicine are further enhanced, and meanwhile the problems that the quality of the product is not stable enough due to environmental change during storage, menthol is volatilized and is easy to crystallize, separate out and deteriorate are effectively solved.
Owner:GUANGXI CHANGHONG PHARM CO LTD

Peach and safflower four-component decoction compound preparation as well as preparation method and quality control method thereof

The invention belongs to the technical field of traditional Chinese medicine preparation, and particularly relates to a peach kernel and safflower four-ingredient decoction compound preparation and a preparation method and a quality control method thereof. The invention provides a preparation method of a peach kernel and safflower four-component decoction compound preparation by screening and optimizing an enrichment method of volatile oil in extraction, concentration, inclusion and drying processes on the basis of an ancient water decoction process. According to the peach kernel and safflower four-drug decoction compound preparation prepared by the invention, the quality consistency with a reference sample is realized, including the consistency of each content index in the compound preparation with the reference sample and the consistency of a fingerprint spectrum with the reference sample; especially, characteristic peaks of volatile components-ligustilide, senkyunolide I and senkyunolide A are presented in the fingerprint spectrum, and the consistency of the content of the volatile oil is determined. Moreover, the quality control method provided by the invention is expected to be used for quality control of industrial large-scale production of a classic famous prescription, namely the peach kernel and safflower four-ingredient decoction compound preparation, and has a good application prospect.
Owner:乔穗桃

Preparation method of nano preparation drug based on polylipoic acid and nano preparation drug

The method comprises the following steps: dissolving lipoic acid and a drug in an organic solvent to form a homogeneous solution, dropwise adding deionized water while stirring, then adding a reducing agent, initiating lipoic acid polymerization and drug co-assembly in situ at 20-40 DEG C to form a drug-loaded micelle solution, and carrying out freeze drying on the drug-loaded micelle solution to obtain the nano-preparation drug based on polylipoic acid. And dialyzing and purifying to obtain the nano preparation medicine based on polylipoic acid. The preparation method is characterized in that lipoic acid has dual characteristics of a drug carrier matrix and a dynamic crosslinking monomer, carrier synthesis and efficient drug encapsulation are synchronously realized through one-step in-situ polymerization-co-assembly, and the technical bottleneck that a traditional nano-carrier needs pre-synthesis and step-by-step drug loading is broken through. The method has the following practicability: (1) the process is simple and efficient, complex equipment is not needed, and reaction conditions are mild; (2) the drug loading performance is excellent, and the particle size is uniform and adjustable (50-300 nanometers); (3) a polylipoic acid skeleton endows the nano-drug preparation with environmental responsiveness, and intelligent drug release can be realized; and (4) the method is suitable for hydrophobic drugs and compound preparations. The method provides a high-load, high-stability and stimuli-responsive nanocrystallization solution for hydrophobic drug delivery, and has application value in the field of nano-medicines.
Owner:GUILIN UNIVERSITY OF TECHNOLOGY

1-((S)-1-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)methyl)phenyl)ethyl)-imidazolidine-2,4-dione derivatives and related compounds as bradykinin (BK) B2 receptor antagonist for treating skin diseases

The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to said compound(s) for use as in a method of treating a skin disorder; eye disease; ear disease; mouth, throat and respiratory disease; gastrointestinal disease; liver, gallbladder and pancreatic disease; urinary tract and kidney disease; disease of male genitale organs and female genitale organs; disease of the hormone system; metabolic disease; cardiovascular disease; blood disease; lymphatic disease; disorder of the central nervous system; brain disorder; musculoskeletal system disease; allergy disorder; pain; infectious disease; inflammatory disorder; injury; immunology disorder; cancer; hereditary disease; or edema.
Owner:PHARVARIS GMBH

Inositol phosphate compounds for use in treating, inhibiting the progression, or preventing cardiovascular calcification

The present invention relates to compounds, pharmaceutical compositions, combined preparations, and dosage regimens for treating, inhibiting the progression, and preventing cardiovascular calcification, and in particular, coronary calcification, aortic artery calcification, and aortic valve calcification comprising inositol phosphates. In a particular aspect the disclosure provides a dosage regimen for treating, inhibiting the progression, or preventing cardiovascular calcification comprising the administration of about 200 mg to about 700 mg of myo-inositol hexaphosphate per administration.
Owner:VIFOR (INT) AG

Donepezil and memantine compound sustained release preparation and preparation process thereof

The invention discloses a donepezil and memantine compound sustained release preparation and a preparation process thereof, and belongs to the technical field of pharmaceutical preparations. The preparation consists of a donepezil hydrochloride quick-release layer and a memantine hydrochloride slow-release layer, wherein the quick-release layer comprises donepezil, starch, mannitol and the like, and realizes quick disintegration through granulation of a low-substituted hydroxypropyl cellulose aqueous solution; the slow-release layer comprises memantine, pinoresinol diglucoside, a polylactic acid-glycolic acid copolymer and chitosan, and the slow-release layer and the composite slow-release material have a synergistic effect through a low-temperature grinding technology, so that the degradation of the memantine is inhibited, and the sustained release of the memantine is controlled. The problem that an existing compound preparation is poor in stability is solved, and a safe and effective treatment choice which is taken once a day is provided for a patient suffering from the Alzheimer disease.
Owner:HANGZHOU CITY XIAOSHAN DISTRICT TRADITIONAL CHINESE MEDICAL HOSPITAL

Olopatadine and brimonidine-containing compound preparation composition for nasal cavity and preparation method thereof

The invention relates to the field of pharmaceutical preparations, and discloses a compound preparation composition containing olopatadine and brimonidine for a nasal cavity and a preparation method of the compound preparation composition. The compound preparation composition for the nasal cavity is prepared from the following components in percentage by weight: 0.01 to 0.5 percent of olopatadine and 0.01 to 0.5 percent of brimonidine. According to the compound preparation composition, olopatadine and brimonidine are combined for use, the curative effect is remarkably improved compared with single-drug treatment, a good synergistic interaction effect is shown, multiple pharmacological effects are achieved through one-time drug administration, and drug use convenience and long-term treatment compliance are greatly improved.
Owner:NANJING DICHANG PHARM TECH CO LTD

In-vitro release method of glucocorticoid compound ointment

The invention relates to the technical field of drug performance testing, and discloses an in-vitro release method of glucocorticoid compound ointment, which comprises the step of performing experiments by adopting a liquid chromatograph and a diffuser. According to the in-vitro release method of the glucocorticoid compound ointment, the same in-vitro release method is adopted to research a compound preparation, so that the operation process is simplified, the time and data problems caused by method difference are reduced, and the analysis efficiency is effectively improved; a set of liquid phase detection method is used for analyzing the compound preparation, so that repeated debugging and frequent switching of detection programs are avoided, the equipment performance is fully excavated, and the liquid phase analysis efficiency is improved; and the method can meet the requirements on sensitivity and distinguishing power of the two components, can accurately discriminate subtle changes of different components, and provides reliable data support for quality control, efficacy evaluation and the like of the compound preparation.
Owner:SUZHOU GAOMAI PHARM CO LTD

Compound preparation containing curcumin nanoparticles as well as preparation method and application of compound preparation

The invention provides a compound preparation containing curcumin nano-particles as well as a preparation method and application of the compound preparation. Curcumin is wrapped by alcohol-soluble protein to form nano-particles, and the nano-particles are used as a Pickering milk solid emulsifier for emulsifying and dispersing vitamin D and olive oil into an oil phase to form a stable droplet structure; furthermore, polysaccharide with enteric characteristics is used as a water-phase carrier material, and the emulsion is encapsulated in the pellet by using a hole sharpening-solidification method, so that the solidification of the liquid medicine (the emulsion) is realized; the three natural components, namely the curcumin, the vitamin D and the olive oil, are ingeniously integrated into a whole; the targeting property of the medicine at the colon part is improved; meanwhile, the destructive effect of the gastrointestinal tract environment on the medicine carrying nanoparticles is reduced.
Owner:FUJIAN HEALTH COLLEGE

Establishment method of HPLC (High Performance Liquid Chromatography) specific chromatogram of cold and heat clearing granules

The invention discloses an establishment method of an HPLC (high performance liquid chromatography) characteristic chromatogram of granules for treating common cold and clearing heat and a component content test thereof, and belongs to the technical field of pharmaceutical analys.According to the research, the HPLC characteristic chromatogram of the granules for treating common cold and clearing heat is established under the same chromatographic condition by adopting a high performance liquid chromatography, and the overall internal quality in a preparation is comprehensively reflected; the method for simultaneously determining the content of amygdalin, puerarin, cimicifugin and corydalis bungeana is established, methodology verifies that the method is simple, convenient and feasible, has good stability and repeatability, and can be used for detection in production process monitoring and quality evaluation of the cold and heat clearing granules to ensure that the quality of the cold and heat clearing granules meets the standard. The scheme not only scientifically restores the overall pharmacodynamic material basis of the compound preparation, but also provides a new generalizable normal form for quality control of traditional Chinese medicines with the advantages of low cost and high efficiency, and has milestone significance for promoting industry standardization and internationalization.
Owner:HEFEI CHINA RESOURCES SHENLU PHARM CO LTD

Method for improving mixing uniformity of metformin and empagliflozin medicine compound preparation

The invention provides a method for improving mixing uniformity of a medicinal compound preparation of metformin and empagliflozin, and belongs to the technical field of medicines. The invention provides an ultrasonic uniform mixing method for dry granulation. The ultrasonic uniform mixing method adopts an air jet pulverization technology, an ultrasonic-assisted vertical shaft planetary stirrer mixing technology and a forced sieving technology, and adopts a strengthening means; by utilizing the synergistic effect of ultrasound and a mixer, the mixing time is shortened, the mixing effect is enhanced, the uniformity and dissolution rate of the preparation are remarkably improved, and the method is short in process route, simple in step operation, easy in condition control and suitable for large-scale production.
Owner:ZHEJIANG UNIV +1

Quality control method of Beijing medicine compound preparation

The invention discloses a quality control method of a Beijing medicine compound preparation, and particularly relates to the field of quality control methods. Comprising the steps of comprehensive detection of medicinal materials, multi-component content determination, biological activity evaluation, quality consistency evaluation and the like. The quality stability of the medicinal materials is guaranteed from the source by determining the medicinal material producing area, the harvesting time and the processing technology preset standard; a biological activity detection model related to efficacy is established, and the quality standard and the efficacy are tightly combined; a compound preparation quality database is constructed, principal component analysis and clustering analysis are used for regular review analysis, and quality control standards and methods are dynamically adjusted and optimized; and a quality early warning mechanism is formulated, and quality problems are handled in time. According to the method, the quality is comprehensively controlled from multiple dimensions, the quality stability of preparations in different batches is ensured, the disjunction of the quality and the efficacy is effectively avoided, and the safety and the effectiveness of the Beijing medicine compound preparation are ensured.
Owner:FANGCHENGGANG TRADITIONAL CHINESE MEDICINE HOSPITAL

Application of dampness-removing and itching-relieving decoction composition based on S1P-S1PRs pathway regulation in treatment of psoriasis

PendingCN120695123ADispersion deliveryDermatological disorderPsoriasis patientSide effect
The invention belongs to the technical field of traditional Chinese medicines, and particularly discloses application of a dampness-removing and itching-relieving decoction composition based on S1P-S1PRs pathway regulation in treatment of psoriasis. According to the present invention, the dampness removing and itching relieving decoction composition is used for treating psoriasis, can provide the treatment effect through multiple ways and multiple targets, can significantly improve the skin lesion condition of psoriasis patients, and can reduce the PASI score; as a traditional Chinese medicine compound preparation, the dampness-removing and itching-relieving decoction composition is small in side effect, high in safety and suitable for long-term use.
Owner:YUNNAN UNIVERSITY OF CHINESE MEDICINE

A method for constructing fingerprint profiles and a method for quality detection of a compound preparation of liver-regulating decoction.

This invention belongs to the field of quality testing technology for traditional Chinese medicine preparations. Specifically, it provides a method for constructing a fingerprint spectrum and a quality testing method for a Tiaogan Decoction compound preparation. The fingerprint spectrum construction method of the Tiaogan Decoction compound preparation described in this invention uses octadecylsilane-bonded silica gel as the packing material and acetonitrile-phosphoric acid aqueous solution as the mobile phase for gradient elution. The elution program was obtained through repeated experiments. Under the elution conditions of this invention, not only is the number of common peaks significantly increased (up to 22), but each common peak also has a good peak shape, good separation effect, and stable baseline. This allows for a more comprehensive, clear, and effective quality testing of the Tiaogan Decoction compound preparation.
Owner:SUZHOU XINZESHENG PHARMACEUTICAL TECHNOLOGY CO LTD

Use of antiviral agents, composition of matter, combination preparations / agents to treat chronic diseases associated with epstein-barr virus and other human herpes viruses

PendingUS20260191871A1MonocytosisFibromyalgia
The present invention is directed to the use of antiviral agents, in particular valomaciclovir stearate and its polymorph Form A, as well as H2G (omaciclovir) to treat multiple sclerosis in combination with other agents, as well as the use of these agents to treat diseases and conditions such as chronic mononucleosis, long COVID, chronic fatigue syndrome, fibromyalgia, Crohn's disease, ulcerative colitis, rheumatoid arthritis, systemic lupus erythematosus, Graves' disease, Alzheimer's disease, mesial temporal lobe seizures, Epstein-Barr-virus-linked autism, or an Epstein-Barr-virus-linked cancer.
Owner:EPIPHANY BIOSCIENCES INC

Combinations containing oxylanthanum carbonate for treating hyperphosphatemia

PendingCA3317758A1Serum phosphateNephrosis
Combinations of oxylanthanum carbonate and tenapanor for reducing serum phosphate levels in patients with end-stage renal disease (ESRD) and / or chronic kidney disease (CKD).
Owner:UNICYCIVE THERAPEUTICS INC

Small molecule therapy for ocular conditions

Provided are pharmaceutical compositions comprising a combination therapy having therapeutically effective amounts of sodium 4-phenyIbutylate and tauroursodeoxycholic acid for the treatment of an ocular condition in a subject. Also provided herein are methods using the combination therapy, and a pharmaceutical composition thereof, for preventing or treating an ocular condition in a subject.
Owner:RGT UNIV OF CALIFORNIA

Tripterine-loaded nanoparticles as well as preparation method and application thereof

The invention belongs to the technical field of medicines, and particularly relates to tripterine-loaded nano-particles as well as a preparation method and application thereof, and the tripterine-loaded nano-particles (Cel-GDNPs) comprise ginger exosome (GDNPs) and tripterine (Cel) encapsulated in the ginger exosome. According to the invention, the Cel is used as a therapeutic drug, and the adopted carrier GDNPs has anti-inflammatory activity, so that when the Cel and the GDNPs are used for treating inflammatory diseases such as colitis and the like, the Cel and the GDNPs can play a multi-component synergistic therapeutic effect, and compared with the single use of the Cel or the GDNPs, the expression of proinflammatory factors (such as TNF-alpha, IL-1beta and IL-6) can be more effectively inhibited, so that the synergistic therapeutic effect is realized; a new strategy is provided for developing a novel natural compound preparation.
Owner:YANTAI UNIV

Method for detecting related substances in dotegravir-emtricitabine-propofol tenofovir compound preparation

PendingCN120233007AComponent separationFluid phaseEmtricitabine
The invention provides a detection method for related substances in a dotegravir-emtricitabine-propofol tenofovir compound preparation. The detection method comprises the following steps of: detecting the related substances in the compound preparation; specifically, the invention provides a high performance liquid chromatography detection method for related substances in a dotegravir-emtricitabine-propofol tenofovir compound preparation, and the method can realize rapid, simple and accurate separation and detection of related substances from dotegravir sodium, emtricitabine and propofol tenofovir fumarate. Therefore, the quality control requirements of the dotegravir-emtricitabine-propofol tenofovir compound preparation can be met.
Owner:SHANGHAI DESANO BIO PHARM CO LTD

A compound preparation for treating vascular dementia and a preparation method thereof

This invention discloses a compound preparation for treating vascular dementia and its preparation method. The active pharmaceutical ingredient consists of protopanaxadiol and gallic acid in a 1:1 mass ratio, and the dosage form is liposomes. The preparation method includes extraction, mixing, liposome preparation, and optional freeze-drying steps: protopanaxadiol and gallic acid are extracted and purified from ginseng rhizome and Terminalia chebula fruit, respectively. After mixing, they are combined with phospholipids and cholesterol to prepare a lipid membrane. The membrane is then homogenized by hydration, low-temperature ultrasound, and high-pressure microfluidic jet to obtain a homogeneous liposome suspension, which can be further freeze-dried into a freeze-dried powder. The 1:1 composition of protopanaxadiol and gallic acid targets multiple points on the pathological mechanism of vascular dementia, showing significant therapeutic effects and broad application prospects. This preparation uses a liposome dosage form to improve the bioavailability of the active ingredient, the preparation process parameters are controllable, the active ingredient has high purity, the liposomes have uniform particle size, high encapsulation efficiency, and good stability.
Owner:GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Method for characterizing volatile components in compound pseudo-ginseng and salvia miltiorrhiza capsules based on gas chromatography-mass spectrometry

ActiveCN121805482AEnrich qualitative identification informationImprove detection efficiencyComponent separationChemical compoundPhysical chemistry
The invention discloses a method for characterizing volatile components in a compound pseudo-ginseng and salvia miltiorrhiza capsule based on gas chromatography-mass spectrometry, and relates to the technical field of compound pseudo-ginseng and salvia miltiorrhiza capsule detection, and the method comprises the following steps: (1) preparing a compound pseudo-ginseng and salvia miltiorrhiza capsule test solution; and (2) detecting the volatile components in the traditional Chinese medicine compound test solution by adopting a triple quadrupole gas chromatograph-mass spectrometer. According to the method, volatile oil of a trace component of rhizoma cyperi in a compound preparation is fully retained and extracted by pre-treating the compound pseudo-ginseng and salvia miltiorrhiza capsule, and after detection by the method, a quasi-molecular ion peak can be obtained, and a fragment ion peak containing rich structure information can be obtained, so that the structure information of the compound can be quickly and accurately obtained.
Owner:THE AFFILIATED HOSPITAL OF YUNNAN UNIVERSITY

Anti-hepatic fibrosis traditional Chinese medicine compound preparation and application thereof

The invention discloses an anti-hepatic fibrosis traditional Chinese medicine compound preparation and application thereof.The anti-hepatic fibrosis traditional Chinese medicine compound preparation is prepared from herba artemisiae scopariae, parched fructus gardeniae, roasted rhizoma atractylodis macrocephalae, turtle shells, radix bupleuri, rhizoma corydalis, herba desmodii styracifolii and herba scutellariae barbatae, all the medicines are compatible and have a synergistic effect, and the effects of clearing heat and promoting diuresis, promoting blood circulation to remove blood stasis, softening hardness to dissipate stagnation and tonifying spleen and qi are achieved together; the liver fibrosis is intervened from a plurality of target spots. Heat clearing and diuresis promoting can eliminate damp-heat evil damaging the liver; blood circulation of the liver can be improved by promoting blood circulation to remove blood stasis, and blood stasis is eliminated; the liver fibrosis hyperplasia can be resisted by softening hardness to dissipate stagnation, and the liver tissue hardening trend can be reversed; spleen invigorating and qi replenishing can enhance healthy qi of the body and improve the self-repairing ability of the liver. The multi-target and all-around treatment mode not only conforms to the holism concept of traditional Chinese medicine, but also conforms to the understanding of modern medicine on multi-factor and multi-link pathogenesis of hepatic fibrosis.
Owner:HANGZHOU XIXI HOSPITAL

Traditional Chinese medicine composition for preventing and treating pregnancy toxemia and compound preparation

The invention belongs to the technical field of veterinary traditional Chinese medicine compositions, and particularly relates to a traditional Chinese medicine composition for preventing and treating pregnancy toxemia and a compound preparation. The traditional Chinese medicine composition for preventing and treating pregnancy toxemia comprises the following raw materials in parts by weight: codonopsis pilosula, astragalus membranaceus, angelica sinensis, radix rehmanniae preparata, ligusticum wallichii and liquorice. The traditional Chinese medicine composition for preventing and treating the pregnancy toxemia can effectively treat the pregnancy toxemia, and after being combined with propylene glycol for use, the traditional Chinese medicine composition has the advantages that raw materials are easy to obtain, the preparation process is simple, administration is simple and easy to operate, toxic and side effects are low, veterinary drug residues are few, the effect taking speed is high, and the effect is good. The invention provides an effective way for preventing and treating the pregnancy toxemia.
Owner:INNER MONGOLIA AUTONOMOUS REGION ACAD OF AGRI & ANIMAL HUSBANDRY SCI

Compound preparation and application thereof

Relates to a compound preparation and application thereof. The compound preparation comprises an anti-VEGF antibody or antigen binding fragment and an integrin GPIIb / IIIa antagonist. According to the compound preparation, the anti-VEGF antibody or antigen binding fragment and the integrin GPIIb / IIIa antagonist in the compound can be kept stable and have good binding activity, and the clinical use safety and effectiveness are improved.
Owner:BIO THERA SOLUTIONS LTD

Combinations comprising lanifibranor and a GLP-1 / GIP / glucagon triple receptor agonist for use in the treatment of liver diseases

The present disclosure relates to a drug combination and a method for the prevention and / or the treatment of a liver disease, the combination comprising lanifibranor or a deuterated form thereof and a GLP-1 / GIP / glucagon triple receptor agonist.
Owner:INVENTIVA

Novel compound preparation for resisting mycobacterium tuberculosis and preparation method thereof

The invention discloses a novel compound preparation for resisting mycobacterium tuberculosis and a preparation method thereof.The compound preparation comprises glutathione active part and pyrazinamide, the weight ratio of glutathione to pyrazinamide is (2-4): 5, the glutathione active part comprises glutathione, an isolation stabilizer, a plasticizer, an anti-sticking agent and a first stabilizer, and the first stabilizer comprises glutathione, an isolation stabilizer, a plasticizer, an anti-sticking agent and a second stabilizer. According to the glutathione active part, firstly, a fluidized powder coating technology is adopted, and the relatively unstable active ingredient glutathione is subjected to powder coating; and preparing the coated components, pyrazinamide, a filler, a second stabilizer, an adhesive, a disintegrating agent and a lubricant into a specific preparation. According to the preparation, the hepatotoxicity during pyrazinamide medication is reduced, the compliance is increased, and meanwhile, the technical problem that a pyrazinamide glutathione preparation is unstable is solved.
Owner:ZHUOHE PHARM GRP CO LTD